Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's Locations section was updated to include a new consolidated Locations heading with entries for New South Wales, Perth, Queensland, and Victoria, while the separate region-specific location entries were removed and the revision tag updated to v3.3.3. The HHS Vulnerability Disclosure link was removed.
    Difference
    0.6%
    Check dated 2025-12-18T21:41:44.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Footer label updated from Revision: v3.2.0 to Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-27T03:49:54.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The government funding lapse notice on the ClinicalTrials.gov page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T22:08:09.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    No meaningful content changes were detected between the old and new screenshots; the study details, sections, and layout appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-29T10:05:21.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    - Added a government funding and operating-status notice and links to official sources; updated version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-07T23:09:29.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    Update: revision version changed from v3.0.2 to v3.1.0, a metadata/branding update with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-30T02:30:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.